Építés alatt – nem éles oldal
Belépés
Résztvevőt keres itt: Egyesült Államok4. fázis

Systemic Oral Glucocorticoids for the Treatment of Acute Osteoarthritis Pain in the Emergency Department

A legfontosabb adatok

Ki végzi
WellSpan Health
Hol
York (Egyesült Államok)A helyszín megnézése
Azonosító
Állapot
Toboroz
Fázis
4. fázis
Résztvevők
192 fő, tervezett
Kezdés
2025. febr. 24.
Várható befejezés
2027. dec.
A vizsgálat típusa
Beavatkozással járó, 3 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
A vizsgált kezelések
  • Prednisone
  • Dexamethasone
  • Placebo
A regiszteradat frissítve
2026. augusztus 19.

Ki vehet részt

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

The trial is looking for adults who come to the emergency department with sudden pain in one knee, hip or shoulder from osteoarthritis. They must be going home from the emergency department.

Életkor
18 years and older
Nem
All sexes
A betegség stádiuma
Sudden pain in one joint (own knee, hip or shoulder), worse than usual, starting less than 72 hour before the visit. Osteoarthritis of that joint must be shown on X-ray now or on earlier imaging.
Korábbi kezelés
Cannot join with an injection into the painful joint within 60 days, a joint replacement of that joint, regular steroid use (more than 5 mg daily prednisone or equivalent in the last 7 days), or daily NSAID use for more than 2 days before the visit.

A részvétel fő kizáró okai

  • Injury to the painful joint within 30 days
  • Heart artery disease, severe stomach or gut bleeding, stomach ulcers, kidney disease with GFR less than 30, or bleeding or platelet disorders
  • Joint pain thought to come from rheumatoid arthritis, gout, joint infection or other inflammatory arthritis
  • Daily prescription opioid use, opioid use disorder, or illegal drug use
  • Allergy or other reasons not to take ibuprofen/NSAIDs, prednisone or dexamethasone; pregnancy; planned hospital stay

A regiszter feltételei, szó szerint

Mind a 20 feltétel megnézéseKevesebb

Ki vehet részt

  • Age ≥18 years
  • Acute monoarticular arthritic joint pain affecting native knee, hip, or shoulder presumed to be related to osteoarthritis
  • Acute pain above baseline starting less than 72 hour prior to ED visit
  • Planned discharge from the ED
  • History of osteoarthritis of the affected joint based on radiography performed at index visit or prior available imaging

Ki nem vehet részt

  • Prior arthroplasty of the affected joint
  • Chronic/baseline use of glucocorticoids (greater than 5 mg daily prednisone or equivalent within previous 7 days) or NSAIDs (daily use for more than 2 days prior to presentation)
  • Illicit drug use
  • Joint pain suspected to be related to rheumatoid arthritis, gout, septic arthritis, or other non-osteoarthritis autoimmune/inflammatory/infectious arthritis
  • Daily prescription opioid use or active opioid use disorder
  • Known allergy/intolerance to ibuprofen/NSAIDs, prednisone, dexamethasone, or other medication precluding ability to participate in one or more study arms
  • Other conditions that would preclude compliance with the study protocol and medication dosing
  • History of coronary artery disease, severe gastrointestinal bleeding, gastric/peptic ulcer disease, chronic kidney disease with GFR less than 30, or platelet disorders (including von Willebrand disease, hemophilia, severe thrombocytopenia with platelets less than 50 k/mcL)
  • Trauma to the affected joint within 30 days
  • Injection of affected joint within 60 days
  • Other contraindications to ibuprofen/NSAIDs or glucocorticoids
  • Planned hospitalization from the ED
  • Pregnancy
  • Incarceration
  • Inability to provide informed consent

Helyszínek itt: Egyesült Államok

  • Wellspan York HospitalYork, Egyesült ÁllamokContact: Kristen OliffRésztvevőt keres

A vizsgálatról

Mit akar kideríteni a vizsgálat

The purpose of this clinical trial is to compare the analgesic effects (relief of pain) of glucocorticoids (steroids) and pain medication versus pain medication alone in adult patients presenting to the emergency department with joint pain due to osteoarthritis. Steroids are drugs that can reduce inflammation and are used commonly for many different medical conditions.

A teljes eredeti leírásKevesebb

In brief, the central aims of the study are to:

1. Assess the efficacy of adding oral glucocorticoid medications to the standard pain medications used to treat the pain of osteoarthritis. 2. Assess the safety and tolerability of oral glucocorticoid medication for the short-term treatment of osteoarthritis pain.

We hypothesize that: 1) The addition of glucocorticoids to standard pain medications will improve reported pain scores at 3 days following the initiation of treatment compared to standard pain medications alone and 2) The use of glucocorticoids will be well tolerated.

Participants in the study will be randomized (like flipping a coin) into one of three groups:

1. Study Group 1 (Control) receiving placebo pills (no active ingredient) once a day for 5 days, plus ibuprofen (pain medication) for 5 days. 2. Study Group 2 (Intervention A) who will receive prednisone (steroid) once a day for 5 days, plus ibuprofen (pain medication) for 5 days. 3. Study Group 3 (Intervention B) who will receive one dose of dexamethasone (steroid) followed by placebo pills (no active ingredient) once a day for 4 days, plus ibuprofen (pain medication) for 5 days.

In all groups, acetaminophen (a different pain medication) can be taken as needed for pain that is not controlled with ibuprofen.

Participants will:

* Receive follow up phone calls at 1, 3, 7 and 14 days. * Report pain scores related to joint pain. * Report the number of pills taken of the various medications used in the study. * Report any adverse events incurred during the follow up period.

A vizsgálat 3 csoportja

  • Intervention A - PrednisoneMár használt kezelés, összehasonlításként

    Subjects assigned to the Intervention A group will receive prednisone 50 mg once a day for 5 days, plus ibuprofen 600 mg every 8 hours for 5 days.

    Kezelés: Prednisone

  • Intervention B - DexamethasoneMár használt kezelés, összehasonlításként

    Subjects assigned to the Intervention B group will receive a single dose of dexamethasone 10 mg, plus ibuprofen 600 mg every 8 hours for 5 days.

    Kezelés: Dexamethasone

  • Control - PlaceboPlacebo, összehasonlításként

    Subjects assigned to the Control group will receive placebo once a day for 5 days, plus ibuprofen 600 mg every 8 hours for 5 days.

    Kezelés: Placebo

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
A regiszteradat frissítve
2026. augusztus 19.